RecruitingNot ApplicableNCT06694155

Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals

Sponsor

University of Arkansas

Enrollment

40 participants

Start Date

Jan 15, 2025

Study Type

INTERVENTIONAL

Conditions

To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals

Min Age: 50 YearsMax Age: 70 Years

Males and females ages 50-70 years.
Capable of providing informed consent.
COVID-19 negative and/or asymptomatic.
Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 7-day study meal period on two occasions.
HbA1c: 5.7-6.4% or 6.5% to 7.5%

Subject who does not/will not eat dairy protein sources.
Subjects taking exogenous insulin injections or GLP /GIP injections or other appetite suppressants.
Unwilling to keep a detailed 7 day food journal on two occasions
Unwilling to wear a CGM for 7 days on two occasions and share the data with the research team.
Lactose intolerance.
Hemoglobin \<10g/dL at screening.
History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment.
History of gastrointestinal bypass/reduction surgery.
Pregnant or lactating individuals.
History of a chronic inflammatory disease (e.g. Lupus, Crohn's disease)
Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy.
Currently using corticosteroid medications (cortisone, hydrocortisone, prednisone, etc.).
Unwilling to avoid using protein or amino-acid supplements during participation.
Unwilling to fast overnight.
Any medical condition or medication that the PI or clinical study staff finds contradictory to this study.